1Littewood TJ. Erythropoietin for the treatment of anemignancy[ J ].Hematol Oncol, 2001,19:19.
2Silvestris F, cafforio P, Grinello D, et al. Upregulation of erythroblast apoptosis by malignant plasma cells:A new pathogenetic mechanism of anemia in multiple myeloma[J]. Rev Clin Exp Hematol,2002,1:39.
3Dammacco F, Luccarelli G, Prete M, et al. The role of recombinant human erythropoietin alpha in the treatment of chronic anemia in multiple myeloma[J ]. Rev Clin Exp Hematol,2002,1: 32.
4Osterborg A. The role of recombinant human erythropoietin in the management of anemia cancer patients: Focous on heamatological malignancies[ J ]. Med Oncol,2000,1:917.
2Stein R S.Abels R l.Krantz S B. Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes [J]. Blood,1991,78: 1658-- 1663.
3Dan L L,Howard H G,Louise B G,et al. Pathophysiology and manifestation of myeloma[J]. MKSAP (oncology),2001,53--55.
4Littlewood T J. Erythropoietin for the treatment of anemia associated with hemotological malignancy [J]. Hematol Oncol.2001.19 : 19-- 30.
5Miyke T, Kung K M, Goldwassere. Purification of human erythropoietin[J]. J Biol Chem, 1977,252:5568-- 5588.
6Krantz S B. Erythopoietin [J]. Blood,1991,77:419-- 422.
7Spovak J L, Recombinant human erythropoietin and the anemia of cancer[J ]. Blood, 1994,84:997--1004.
8Miller C B, Jones R J, Piantadosi S,et al. Decreased erythropoietin response in patients with the anemia of cancer[J]. N Engl J Med, 1990,322 : 1689-- 1691.
9Coffier B. Anemia associated with non-platinum chemotherapy ( CT ) for Hodgkin's lymphoma (HL) or non-Hodgkin's lymphoma (NHL) [J]. ECCO.1999.35:19-- 22.
10Henry D H,Abels R I. Recombinant human erythropoietin in the treatment of cancer and chemotherapy. Induced anemia:results of double-blind and open-la-bel fellow-up studies [J]. Seminars in Oncology, 1994,21 : 21 -- 28.
4Kasper C,Tehaar A,Fossa A,et al.Recombinant human erythropoietin in the treatment of cancerrelated anaemia.Eur J Haematol,1997,58 (4):251.
5Piacibello W,sanavio F,Brizzi MF,et al.Megaryocyte growth and development factor (MGDF)-induced acute leukemia cell proliferation and clonal growth is associated with functional cmpl.Leukemia,1997,11(4):531.
6Schiffer CA,Miller K,Larson RA,et al.A double-blind placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor as an adjunct to induction and consolidation therapy for patients with acute myeloid leukemia.Blood,2000,95 (8):2530.
8Mauricette Michallet,Karine Goldet,Mohamad Sobh,Stéphane Morisset,Youcef Chelghoum,Xavier Thomas,Fiorenza Barraco,Sophie Ducastelle,Hélène Labussière,Catherine Renzullo,Carole Paillet,Christine Pivot,Perrine Badol‐Van Straaten,Angelique Denis,Anne Termoz,Marie Detrait,Franck‐Emmanuel Nicolini,Isabelle Jaisson‐Hot.Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients[J].Cancer.2012(1)
